Fundrise “IPO” May Pay Off for Investors in 2021

Recovery for commercial real estate this year may be uncertain, but the team at Fundrise doesn’t seem to be concerned. With a diverse investment strategy, the company’s unique approach to raising capital is likely to pay off for investors in 2021. Fundrise is a crowdfunding app for commercial real estate. No big deal, right? There…
[Read More]

Big Tobacco is Making Moves in the Cannabis Industry

In the 1980s, Oldsmobile produced the best-selling cars in America. In 2004, the last Oldsmobile rolled off the assembly line and the brand was discontinued. The history of US businesses is filled with similar stories. Does anyone remember Compaq computers? Here’s another name to throw in the hat. RJ Reynolds. Don’t bother looking for them…
[Read More]

The Future of Cancer Immunotherapy After COVID-19

In 2020, nearly 2 million cases of cancer were diagnosed in the United States. More than 600,000 people died from the disease. 40% of us will be diagnosed with cancer at some point. Surprisingly, cancer rates are highest in the most developed countries. Cancer is a present and very often tragic reality in many people’s…
[Read More]

Direct Listings Open New Doors for Independent Investors

The transfer of wealth from Wall Street to Main Street, once a nebulous concept, received another shot in the arm this month. Coinbase, one of the hottest IPO prospects for 2021, chose the direct listing route. They are not the first, and they won’t be the last this year. Despite posting a profit of $320…
[Read More]

Leafwire Shines a Light on Reg CF for the Cannabis Sector

Imagine a $30 billion industry in the United States without access to traditional banking services. It sounds like fiction, but it’s a true story. The cannabis sector, despite huge strides in their quest for legitimacy, still lacks the means to tap into funding from FDIC banks. That didn’t stop Peter Vogel. As CEO of Leafwire,…
[Read More]

Microcaps Continue to Outperform the S&P 500 in 2021

Stop listening to all the noise about short squeezes. Forget the stimulus check that you may or may not get this quarter. It’s time to look at some real numbers. We’re two months into a new year, and investors continue to trend towards microcaps. The data proves it. The Russell Microcap Index, viewed by institutional…
[Read More]

The Real League of Legends: Smart Gaming Stocks for Investors

From Minecraft to Super Mario Bros., video games have captivated players worldwide since they reached mainstream popularity in the 1970s and ‘80s. The pandemic only magnified interest in gaming: As Covid-19 kept many consumers at home, video game sales worldwide surged 20% to a staggering $180 billion. Today, three out of four Americans, or roughly 244 million…
[Read More]

The Diamond Market’s Post-COVID Prospects

Diamonds may be a girl’s best friend, but volatility in the diamond market last year left boys and girls alike feeling less than friendly toward their precious gem investments. Fortunately, in spite of last year’s unique challenges, the market managed to regain its composure and is poised for future growth. Tapped Out and Locked Down…
[Read More]

How to use swing trading to exploit a hyped-up retail marketplace

Despite soaring from below $10,000 to above $30,000 at the beginning of the year, Bitcoin feels like yesterday’s news. As 2021 grows one month older, the only subject anyone wants to talk about is the insanity behind the GameStop and AMC price explosions. While the retail craze will eventually settle, the momentum behind the world’s…
[Read More]

Is Bitcoin the New “Safety Net” for Investors?

History has many lessons to teach us. Take the Spanish dollar as an example. The first recognized global currency, known popularly as “pieces of eight,” was valuable because it was widely accepted around the globe. It maintained its popularity for three centuries. Silver itself had no practical use in the 17th Century, when the Spanish…
[Read More]

It’s Going to Take More Than Vaccines to Fight This Pandemic

For the past year, investors across the world have trained their sights on vaccine development. Why wouldn’t they? Over and over, we’ve been told that only a vaccine will get us out of this.  But, the vaccine is only one weapon in our arsenal, and we’d be wise to remember that. Vaccines cannot provide complete…
[Read More]